Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model
about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaThe role of Wnt signaling in the development of Alzheimer's disease: a potential therapeutic target?Huperzine A ameliorates cognitive deficits in streptozotocin-induced diabetic ratsHuperzine A: Is it an Effective Disease-Modifying Drug for Alzheimer's Disease?Intranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease.Genetic analysis of cortical thickness and fractional anisotropy of water diffusion in the brain.The protection of acetylcholinesterase inhibitor on β-amyloid-induced the injury of neurite outgrowth via regulating axon guidance related genes expression in neuronal cells.Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer's diseaseNatural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect.Prostaglandin I2 upregulates the expression of anterior pharynx-defective-1α and anterior pharynx-defective-1β in amyloid precursor protein/presenilin 1 transgenic mice.Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.Wnt signaling: role in Alzheimer disease and schizophrenia.Wnt and lithium: a common destiny in the therapy of nervous system pathologies?The discovery and development of new potential antioxidant agents for the treatment of neurodegenerative diseases.Huperzine A Alleviates Oxidative Glutamate Toxicity in Hippocampal HT22 Cells via Activating BDNF/TrkB-Dependent PI3K/Akt/mTOR Signaling Pathway.Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.Hypoxia-triggered m-calpain activation evokes endoplasmic reticulum stress and neuropathogenesis in a transgenic mouse model of Alzheimer's disease.Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms.Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice.Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury.Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.TL-2 attenuates β-amyloid induced neuronal apoptosis through the AKT/GSK-3β/β-catenin pathway.Lower Expression of Ndfip1 Is Associated With Alzheimer Disease Pathogenesis Through Decreasing DMT1 Degradation and Increasing Iron Influx.
P2860
Q21129335-ECA7847F-1FC9-40EB-B930-E2978EAFC711Q28075617-AEDDCADE-E8CA-4D55-B736-DFA8A606DCADQ33634629-16FC821F-E93A-4181-8790-D12B86A8540CQ33755620-124DBED1-092A-4B7A-954E-1C2F39AA56DFQ34063312-62286F83-CD93-49D0-90A1-C2AE2FECE6DEQ34998572-A166E03F-3C17-4D07-BE1F-23EFB1F6DA7BQ35424377-77C226B3-E810-476E-9A90-DA5362F430C8Q36358021-C41C6408-F0DA-44D1-BFE8-483442B11FB1Q36689057-1691DECC-5FEB-45C7-B393-FC6C529D9671Q37098664-0F1488B7-D14E-47B2-8362-91C8DD77A9B8Q37235602-AF78E1C3-D824-4EDA-A447-29CEF78FAA0CQ37406597-6C8CE950-327F-47B2-AFB5-084D78DC252AQ38060562-36DA6B6B-6DB2-4DAA-8123-612CEF6C5A55Q38113139-8A82A37A-2F2F-4B40-86F1-58AB7DA4E7F7Q38233270-65BD638E-31BE-4EA0-8D8C-48B9691E9242Q38829993-A24DBE16-2296-4419-9AA5-67FECB5EB0EAQ39009840-F1A1CF43-652A-40FA-B8C7-71DE7119EC81Q39119944-B8ADAB21-61C6-4B34-AA8F-871B9E2CCD74Q39214249-7DDB1315-7B0C-48C3-A72F-0748A0F0D864Q39457273-CC9B6176-C3D1-4FD4-97A0-29110038879AQ46330122-9EFA1B19-E356-4382-8780-CABF8E9E9F39Q46606963-5D74E0CE-A87B-4FC0-90C5-A26F8F354450Q49393483-660A9816-3698-4E9A-AAEA-49244BF375D4Q50676721-56399224-E5C2-4D06-8027-62CF4A3435ECQ55414493-E9484BEF-AC0E-451F-9C9D-9D8F3C353CC4
P2860
Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@ast
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@en
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@nl
type
label
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@ast
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@en
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@nl
prefLabel
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@ast
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@en
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@nl
P2093
P2860
P356
P1476
Huperzine A activates Wnt/β-ca ...... zheimer transgenic mouse model
@en
P2093
Bao-Lu Zhao
Chun-Yan Wang
Jing-Wei Xie
Si-Ling Wang
Wei-Ping Teng
Zhan-You Wang
P2860
P2888
P304
P356
10.1038/NPP.2010.245
P407
P577
2011-02-02T00:00:00Z
P5875
P6179
1002054744